Telomir Pharmaceuticals, Inc (TELO) insider trading
Every open-market stock purchase and sale by Telomir Pharmaceuticals, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- Last insider buy: Bay Shore Trust (Insider), $343K, 2 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales). Last close $1.01 on Oct 22, 2026.
Recent TELO insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| May 21, 2026 | Erez Aminov (CEO) | Sold (not open market) | $9.8M |
| May 21, 2026 | Erez Aminov (CEO) | Sold (not open market) | $4.2M |
| May 21, 2026 | Erez Aminov (CEO) | Bought (not open market) | $2.6M |
| May 21, 2026 | Erez Aminov (CEO) | Bought (not open market) | $2.5M |
| May 21, 2026 | Matthew Paul Del Giudice (Director) | Sold (not open market) | $126K |
| May 21, 2026 | Edward Clouston MacPherson (Director) | Sold (not open market) | $126K |
| May 21, 2026 | Matthew Pratt Whalen (Director) | Sold (not open market) | $126K |
| May 21, 2026 | Matthew Pratt Whalen (Director) | Bought (not open market) | $32.5K |
| May 21, 2026 | Matthew Paul Del Giudice (Director) | Bought (not open market) | $32.5K |
| May 21, 2026 | Edward Clouston MacPherson (Director) | Bought (not open market) | $32.5K |
| Apr 22, 2026 | Erez Aminov (CEO) | Bought (not open market) | $10M |
| Apr 16, 2026 | Matthew Pratt Whalen (Director) | Bought (not open market) | — |
| Apr 16, 2026 | Edward Clouston MacPherson (Director) | Bought (not open market) | — |
| Apr 16, 2026 | Matthew Paul Del Giudice (Director) | Bought (not open market) | — |
Who's trading TELO
- Matthew Pratt Whalen, Director: other filings, last May 21, 2026
- Matthew Paul Del Giudice, Director: other filings, last May 21, 2026
- Erez Aminov, CEO: other filings, last May 21, 2026
- Edward Clouston MacPherson, Director: other filings, last May 21, 2026
Get free alerts when an insider at Telomir Pharmaceuticals, Inc files a new trade →